SITC Archive Library

On January 25, 2021, leading experts in cancer immunotherapy presented an overview of the publication "Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immunotherapy for the treatment of lymphoma" during a live webinar. The recorded webinar and presentation slides are available below.

Webinar Faculty:

• Moderator: Michael R. Bishop, MD – University of Chicago (Expert Panel Chair)
  
• Sattva S. Neelapu, MD – The University of Texas MD Anderson Cancer Center (Expert Panel Chair)
• Stephen M. Ansell, MD, PhD – Mayo Clinic Cancer Center (Expert Panel Member)

The webinar discussed: 

• SITC's clinical practice guideline on immunotherapy for the treatment of lymphoma
• Approved immunotherapies for Hodgkin lymphoma, non-Hodgkin lymphoma, and chronic lymphocytic leukemia
• Management of immune-related adverse events for lymphoma
• Case studies on lymphoma

Disclaimer: Due to the rapidly-evolving field of cancer immunotherapy, some of the content on this page may be out of date. For current information from SITC on cancer immunotherapy, please visit connected.sitcancer.org.

This webinar is supported, in part, by independent medical education grant funding from Amgen, AstraZeneca Pharmaceuticals LP, Celgene Corporation and Merck & Co., Inc.

Please note that the on-demand webinar is not available for continuing education credits

#Lymphoma #RecordedWebinar #PresentationSlides #ClinicalPracticeGuideline #Clinician #NursePractitioner #Pharmacist #PrimaryCarePhysician #RegisteredNurse #2021 #ClinicalTrials #AdoptiveCellTherapy #AntibodyDrugConjugates #ImmuneCheckpointInhibitors #TherapeuticAntibodies #AdverseEvents